Differential diagnoses are broad; infection(viral,fungal,bacterial) vs. tumour lysis vs. drug toxicity(e.g., cardiac dysfunction) . Aetiology sometimes hard to find. https://t.co/BFOHXs90Kf
RT @georgepapadapol: Otro grupo con beneficio probado son los pacientes inmunocomprometidos no relacionados al SIDA (malignidades hematológ…
Otro grupo con beneficio probado son los pacientes inmunocomprometidos no relacionados al SIDA (malignidades hematológias y sólidas, enfermedades sistémicas, transplantados) con FRA hipoxémica: 👉https://t.co/ifaUyy9xJI https://t.co/uOTkLjqx2S
RT @avkwong: The EFRAIM study: Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective coho…
RT @avkwong: The EFRAIM study: Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective coho…
RT @avkwong: The EFRAIM study: Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective coho…
RT @avkwong: The EFRAIM study: Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective coho…
Using HFNC to reduce intubation rate for immunocompromised patients with no increase in mortality noted is a positive outcome. Especially patients with malignancy. Buying more days that allow better interaction with family and greater comfort is meaningful
RT @avkwong: The EFRAIM study: Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective coho…
The EFRAIM study: Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study. Which showed a benefit to rate of intubations but not mortality #LIVES2018 https://t.co/yUPXT45fVU
RT @YaseenarabiYa: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co/feoz4PNOwR
RT @YaseenarabiYa: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co/feoz4PNOwR
RT @YaseenarabiYa: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co/feoz4PNOwR
Acute hypoxemic respiratory failure in immunocompromised patients https://t.co/feoz4PNOwR
RT @georgepapadapol: Impacto del manejo inicial para tratar Insuficiencia respiratoria aguda hipoxémica en pacientes inmunocompremetidos no…
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
RT @Fluid_Academy: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in... https://t.co/GXKl5XVfwH by #HCS…
Impacto del manejo inicial para tratar Insuficiencia respiratoria aguda hipoxémica en pacientes inmunocompremetidos no relacionada a SIDA (malignidades hematológias y sólidas, enfermedades sitémicas, transplantados): #LIVES2017 https://t.co/ifaUyy9xJI http
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
#LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in... https://t.co/GXKl5XVfwH by #HCSMnews https://t.co/PlTLCvtbjv
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
RT @yourICM: #LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co…
#LIVES2017 The President's session highlights: Acute hypoxemic respiratory failure in immunocompromised patients https://t.co/OBumaULzMq https://t.co/cc6QaLj11J